Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin - PubMed (original) (raw)
Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin
Yu-Lin Yang et al. Biochem J. 2004.
Abstract
Diabetic nephropathy is characterized by early hypertrophy in both glomerular and tubuloepithelial elements. However, no studies to date have established a direct causal link between hyperglycaemia and renal hypertrophy. Our previous studies have found that high glucose does not induce cellular hypertrophy or expression of TGF-beta1 (transforming growth factor-beta1) in distal renal tubule cells [Yang, Guh, Yang, Lai, Tsai, Hung, Chang and Chuang (1998) J. Am. Soc. Nephrol. 9, 182-193]. In the present study, we used AGEs (advanced glycation end-products) to mimic long-term hyperglycaemia. Similar to glucose, AGEs did not induce TGF-beta1 mRNA in distal renal tubule cells [MDCK (Madin-Darby canine kidney) cells]; however, TGF-beta1 bioactivity was increased significantly. This result indicated post-translational regulation. Since TSP-1 (thrombospondin-1) has been demonstrated to activate latent TGF-beta1 in a variety of systems, the following experiments were performed. We found that AGEs dose-dependently increased both intracellular and extracellular levels of TSP-1. Purified TSP-1, like AGEs, increased the cellular protein content. Furthermore, anti-TSP-1 neutralizing antibodies attenuated the AGE-induced increase in TGF-beta1 bioactivity and hypertrophy. Thus TSP-1 might mediate AGE-induced distal renal tubule hypertrophy. In addition, we observed several putative transcription factor binding sites in the TSP-1 promoter, including those for AP-1 (activator protein-1), CREB (cAMP response element binding protein), NF-kappaB (nuclear factor-kappaB), SRF (serum response factor) and HSF (heat-shock factor), by sequence mapping. We used an enhancer assay to screen possible transcription factors involved. We showed that AP-1 and CREB were specifically induced by AGEs; furthermore, TFD (transcription factor decoy) for AP-1 could attenuate the AGE-induced increases in TSP-1 levels and cellular hypertrophy. Thus regulation of TSP-1 might be critical for hyperglycaemic distal tubule hypertrophy. Furthermore, TSP-1 TFD might be a potential approach to ameliorate diabetic renal hypertrophy.
Similar articles
- Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota.
Chuang LY, Guh JY, Liu SF, Hung MY, Liao TN, Chiang TA, Huang JS, Huang YL, Lin CF, Yang YL. Chuang LY, et al. Biochem J. 2003 Oct 15;375(Pt 2):385-93. doi: 10.1042/BJ20030522. Biochem J. 2003. PMID: 12841849 Free PMC article. - Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
Wahab NA, Schaefer L, Weston BS, Yiannikouris O, Wright A, Babelova A, Schaefer R, Mason RM. Wahab NA, et al. Diabetologia. 2005 Dec;48(12):2650-60. doi: 10.1007/s00125-005-0006-5. Epub 2005 Nov 4. Diabetologia. 2005. PMID: 16270194 - Thrombospondin 1 does not activate transforming growth factor beta1 in a chemically defined system or in smooth-muscle-cell cultures.
Grainger DJ, Frow EK. Grainger DJ, et al. Biochem J. 2000 Aug 15;350 Pt 1(Pt 1):291-8. Biochem J. 2000. PMID: 10926856 Free PMC article. - The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN. Chen S, et al. Ren Fail. 2001 May-Jul;23(3-4):471-81. doi: 10.1081/jdi-100104730. Ren Fail. 2001. PMID: 11499562 Review. - Transforming growth factor-β1 and diabetic nephropathy.
Chang AS, Hathaway CK, Smithies O, Kakoki M. Chang AS, et al. Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F689-F696. doi: 10.1152/ajprenal.00502.2015. Epub 2015 Dec 30. Am J Physiol Renal Physiol. 2016. PMID: 26719364 Free PMC article. Review.
Cited by
- IGF-I combined with exercise improve diabetes-induced vascular dysfunction in heart of male Wistar rats.
Niknam Z, Samadi M, Ghalibafsabbaghi A, Chodari L. Niknam Z, et al. J Cardiovasc Thorac Res. 2022;14(1):34-41. doi: 10.34172/jcvtr.2021.54. Epub 2021 Dec 16. J Cardiovasc Thorac Res. 2022. PMID: 35620752 Free PMC article. - Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications.
Xu L, Zhang Y, Chen J, Xu Y. Xu L, et al. J Diabetes Res. 2020 Jun 11;2020:8043135. doi: 10.1155/2020/8043135. eCollection 2020. J Diabetes Res. 2020. PMID: 32626782 Free PMC article. Review. - Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.
Murphy-Ullrich JE. Murphy-Ullrich JE. J Histochem Cytochem. 2019 Sep;67(9):683-699. doi: 10.1369/0022155419851103. Epub 2019 May 22. J Histochem Cytochem. 2019. PMID: 31116066 Free PMC article. Review. - Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.
Murphy-Ullrich JE, Suto MJ. Murphy-Ullrich JE, et al. Matrix Biol. 2018 Aug;68-69:28-43. doi: 10.1016/j.matbio.2017.12.009. Epub 2017 Dec 27. Matrix Biol. 2018. PMID: 29288716 Free PMC article. Review. - Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland.
Aupperlee MD, Zhao Y, Tan YS, Leipprandt JR, Bennett J, Haslam SZ, Schwartz RC. Aupperlee MD, et al. Endocrinology. 2014 Jun;155(6):2301-13. doi: 10.1210/en.2013-1933. Epub 2014 Apr 2. Endocrinology. 2014. PMID: 24693965 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11704-8 - PubMed
- J Biol Chem. 1995 Mar 31;270(13):7304-10 - PubMed
- Biochem Biophys Res Commun. 1995 Apr 6;209(1):73-9 - PubMed
- Methods Enzymol. 1994;245:62-85 - PubMed
- Rinsho Byori. 1995 May;43(5):445-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous